Author

Jing Wei Neo

Observed name: Jing Neo

Institution: Health Sciences Authority

Observed institution: Health Sciences Authority

ORCID: 0000-0002-4075-892X

Observed ORCID: 0000-0002-4075-892X

OpenAlex ID: A5034268635

Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in Singapore

2023 · Sreemanee Raaj Dorajoo, Hui Xing Tan, et al. · Vaccine X · 13

Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea

2022 · Hui Xing Tan, Desmond Chun Hwee Teo, et al. · Healthcare Informatics Research · 9

Unlocking Potential of Generative Large Language Models for Adverse Drug Reaction Relation Prediction in Discharge Summaries: Analysis and Strategy

2025 · Yen Ling Koon, Hui Xing Tan, et al. · Clinical Pharmacology & Therapeutics · 6

Effectiveness of Transformer-Based Large Language Models in Identifying Adverse Drug Reaction Relations from Unstructured Discharge Summaries in Singapore

2025 · Yen Ling Koon, Yan Tung Lam, et al. · Drug Safety · 5

Myasthenia gravis following the initiation of statin therapy: A multinational self‐controlled case series study

2026 · Vincent Ka Chun Yan, Wanchun Xu, et al. · Journal of Internal Medicine · 4

Phenotyping Diabetes Mellitus on Aggregated Electronic Health Records from Disparate Health Systems

2023 · Hui Tan, Rachel Lim, et al. · Pharmacoepidemiology · 1

Authors’ reply: Myasthenia gravis following the initiation of statin therapy

2026 · Vincent Ka Chun Yan, Wanchun Xu, et al. · Journal of Internal Medicine

Pioneering Arterial Hypertension Phenotyping on Nationally Aggregated Electronic Health Records

2024 · Jing Wei Neo, Qihuang Xie, et al. · Pharmacoepidemiology

Works count: 8

Citation count: 38

H-index: 4

I10-index: 1